New Enterprise Associates 16, L.P.
Related Filers (13)
- NEA 16 GP, LLC (27)
- NEA Partners 16, L.P. (27)
- GENOCEA BIOSCIENCES, INC. (11)
- Trevi Therapeutics, Inc. (9)
- Mirum Pharmaceuticals, Inc. (6)
- Regulus Therapeutics Inc. (5)
- Akouos, Inc. (5)
- Growth Equity Opportunities V, LLC (5)
- Metacrine, Inc. (5)
- Marker Therapeutics, Inc. (4)
- X4 Pharmaceuticals, Inc (3)
- Allakos Inc. (3)
- Black Diamond Therapeutics, Inc. (2)
- Show More ...
Ownership (53)
SC 13D/A
Friday, 12/29/2023
Mirum Pharmaceuticals, Inc.: Major Shareholders
SC 13D/A
Friday, 6/23/2023
Mirum Pharmaceuticals, Inc.: Major Shareholders
4
Thursday, 6/15/2023
Mirum Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/2/2022
Akouos, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Friday, 10/28/2022
Akouos, Inc.: Major Shareholders
SC 13D
Tuesday, 10/11/2022
Allakos Inc.: Major Shareholders
SC 13D/A
Friday, 5/27/2022
GENOCEA BIOSCIENCES, INC.: Major Shareholders
4
Thursday, 5/26/2022
GENOCEA BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
SC 13D/A
Monday, 4/25/2022
Trevi Therapeutics, Inc.: Major Shareholders
4
Wednesday, 4/13/2022
Trevi Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 1/5/2022
Metacrine, Inc.: Major Shareholders
4
Monday, 12/27/2021
Metacrine, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 11/2/2021
Trevi Therapeutics, Inc.: Major Shareholders
4
Tuesday, 10/19/2021
Trevi Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 4/14/2021
GENOCEA BIOSCIENCES, INC.: Major Shareholders
SC 13D/A
Friday, 3/26/2021
Marker Therapeutics, Inc.: Major Shareholders
4
Thursday, 3/18/2021
Marker Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/16/2021
Regulus Therapeutics Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Thursday, 3/11/2021
Allakos Inc.: Major Shareholders
4
Monday, 12/7/2020
Regulus Therapeutics Inc.: Statement of changes in beneficial ownership of securities
SC 13D
Monday, 9/28/2020
Metacrine, Inc.: Major Shareholders
4
Tuesday, 9/22/2020
Metacrine, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 9/15/2020
Metacrine, Inc.: Initial statement of beneficial ownership of securities
SC 13D/A
Monday, 8/3/2020
GENOCEA BIOSCIENCES, INC.: Major Shareholders
4
Tuesday, 7/28/2020
GENOCEA BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
SC 13D
Tuesday, 7/7/2020
Akouos, Inc.: Major Shareholders
4
Wednesday, 7/1/2020
Akouos, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 6/25/2020
Akouos, Inc.: Initial statement of beneficial ownership of securities
SC 13D/A
Thursday, 4/16/2020
Trevi Therapeutics, Inc.: Major Shareholders
4
Monday, 4/13/2020
Trevi Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D
Thursday, 2/13/2020
Black Diamond Therapeutics, Inc.: Major Shareholders
3
Wednesday, 1/29/2020
Black Diamond Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 12/26/2019
Regulus Therapeutics Inc.: Statement of changes in beneficial ownership of securities
SC 13D
Tuesday, 7/30/2019
Mirum Pharmaceuticals, Inc.: Major Shareholders
4
Wednesday, 7/24/2019
Mirum Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 7/17/2019
Mirum Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
SC 13D/A
Friday, 6/28/2019
GENOCEA BIOSCIENCES, INC.: Major Shareholders
4
Tuesday, 6/25/2019
GENOCEA BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 5/28/2019
X4 Pharmaceuticals, Inc: Major Shareholders
SC 13D
Monday, 5/20/2019
Trevi Therapeutics, Inc.: Major Shareholders
4
Monday, 5/13/2019
Trevi Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/9/2019
Regulus Therapeutics Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 5/7/2019
Trevi Therapeutics, Inc.: Initial statement of beneficial ownership of securities
SC 13D/A
Friday, 2/22/2019
GENOCEA BIOSCIENCES, INC.: Major Shareholders
4
Tuesday, 2/19/2019
GENOCEA BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
SC 13D
Thursday, 10/25/2018
Marker Therapeutics, Inc.: Major Shareholders
3
Thursday, 10/18/2018
Marker Therapeutics, Inc.: Initial statement of beneficial ownership of securities
SC 13D
Friday, 7/27/2018
Allakos Inc.: Major Shareholders
SC 13D
Friday, 1/26/2018
GENOCEA BIOSCIENCES, INC.: Major Shareholders
3
Tuesday, 1/23/2018
GENOCEA BIOSCIENCES, INC.: Initial statement of beneficial ownership of securities
SC 13D
Wednesday, 11/29/2017
Arsanis, Inc.: Major Shareholders
3
Monday, 11/20/2017
Arsanis, Inc.: Initial statement of beneficial ownership of securities
3
Monday, 7/31/2017
Regulus Therapeutics Inc.: Initial statement of beneficial ownership of securities